Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner
These findings demonstrate that antiretroviral therapy, when taken until viral suppression is achieved and sustained, is a highly effective, durable intervention for HIV prevention.
The labs of Jean Cook, PhD, and Jeremy Purvis, PhD, will develop the first-ever interactive molecular model of a crucial cellular process that controls healthy growth and diseases such as cancer.
UNC’s Brian Strahl, PhD, and Van Andel Research Institute’s Scott Rothbart, PhD, create a robust online interactive database to address science’s ‘antibody crisis’.
Noninvasive prenatal screening tests may detect underlying maternal conditions, including cancer, in the mother, according to a study published July 13 in the Journal of the American Medical Association on which Dr. Neeta Vora, a clinical geneticist and assistant professor of maternal-fetal medicine at UNC's Department of Obstetrics and Gynecology, is co-author.
A survey of college-aged women finds that those with the strongest emotional connection to Facebook are less likely to struggle with risky dieting behaviors compared to their peers.
The finding published in PLoS One suggests that elevated oxidized LDL cholesterol and fructosamine – a measure of glycated proteins in blood sugar – are signposts for the development of severe coronary disease, especially in females.
Their article, published in The New England Journal of Medicine, explores the pros and cons of five different interventional approaches to treating gallbladder disease – a condition that affects more than 25 million Americans.
UNC OB-GYN's Division of Maternal-Fetal Medicine has unveiled a free, web-based calculator to help providers better counsel patients on the benefits and risks of the four most common screening tools for fetal genetic abnormalities available commercially in the U.S.
A UNC core facility churns out radioactive agents to investigate the subcellular activity that drives disease.
Clinical trials studying kidney disease usually use end-stage kidney disease as the primary outcome, or end point, of a study. For many kidney diseases end-stage kidney disease may not occur for several years, sometimes 10 or more. A new paper examines surrogate endpoints. Patrick Nachman, MD, of the UNC Kidney Center, is one of the paper's authors.
UNC School of Medicine researchers provide first direct experimental evidence for the rapid synthesis of two classes of proteins necessary to create the first life on Earth.
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The $500,000 grant will allow Jeffrey Stirman, PhD, a postdoc biomedical engineer at UNC, to develop a new kind of microscope and study the brain like never before.
Jenny Ting, PhD, a UNC Lineberger Comprehensive Cancer Center member and the William R. Kenan Jr. Professor of Microbiology and Immunology at the UNC School of Medicine, has studied genetic and molecular mechanisms behind immune system development for more than three decades at UNC. Now she’s helping to lead two major federal center grants to further vaccine development and boost our understanding of immune responses to viruses.
The assessment not only identifies the roadblocks to treatment, but also provides a path to overcoming them.
The experimental treatment uses a genetically modified virus to deliver a missing gene into the cerebrospinal fluid of children with giant axonal neuropathy (GAN).
Graduate student Sarah Shelton reinvented herself from a dancer to a scientist. Now, she’s creating a new ultrasound technique to improve cancer diagnostics.
A freshman professor when Michael Jordan was a first-year student-athlete, Keith Burridge, PhD, has dedicated his career to elucidating the intricate structures of cells that allow cancers to metastasize.
University of North Carolina researchers provide evidence for how the genetic code developed in two distinct stages to help primordial chemicals evolve into cells.